Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000757405 | SCV000751668 | likely benign | not provided | 2023-12-29 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000757405 | SCV000885612 | likely benign | not provided | 2017-06-26 | criteria provided, single submitter | clinical testing | The c.2778A>G variant has not been previously associated with any peripheral neuropathy. This variant is rare in the general population, and is listed in the Genome Aggregation Database (gnomAD) browser with a frequency in non-Finnish Europeans of 0.004% (identified in 4 out of 111,180 chromosomes). However, this variant affects a weakly conserved nucleotide (Alamut software v 2.9), does not alter the amino acid sequence of IKBKAP protein, and is not predicted to alter IKBKAP mRNA splicing (Alamut software v 2.9). Therefore, the c.2778A>G variant is likely to be benign. |
Ambry Genetics | RCV004025388 | SCV002755117 | likely benign | not specified | 2019-07-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002492944 | SCV002802366 | likely benign | Medulloblastoma; Familial dysautonomia | 2021-12-20 | criteria provided, single submitter | clinical testing |